One Mind is offering three (3) 2023 One Mind Rising Star Awards to advance rigorous, evidence-based scientific research with great potential to benefit people living with psychiatric disorders and the mental healthcare system.
The One Mind Rising Star Awards identify and fund pivotal, innovative research on the causes of and cures for brain health conditions by supporting the most promising emerging leaders in the field of neuropsychiatry.
The three awards are:
- 2023 One Mind–Ben Langford and Nicholas Hall Rising Star Award
- 2023 One Mind–Luther Family Rising Star Award
- 2023 One Mind–Russ and Stephanie Deyo Rising Star Award
One Mind is grateful for the support from the Luther, Deyo, Langford and Hall families for their generous contributions that make these awards possible.
- One Mind Rising Star Research Awards:
- The 2023 One Mind Rising Star Awards will support grant proposals spanning basic/preclinical, translational, and clinical research for psychiatric disorders.
- These include, but are not limited to, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder, eating disorders, post-traumatic stress disorder, anxiety disorders, and suicidality. Studies at the intersection of addiction/substance use disorders and psychiatric disorders are within scope.
- Autism spectrum disorder, attention deficit/hyperactivity disorder, and neurodegenerative disorders are out of scope.
- Each 2023 One Mind Rising Star Award winner will receive:
Examples of relevant research proposals include, but are not limited to, studies that aim to:
- Discover the molecular/genetic, synaptic, cellular, or circuit/network basis of psychiatric disorders in model organisms or humans.
- Advance biomarker development to improve diagnosis and/or treatment outcomes.
- Investigate common mechanisms of brain dysfunction between two or more disorders.
- Develop new experimental or computational approaches/model/tools for a sophisticated understanding of disease etiology, pathophysiology, resilience, and/or recovery.
- Evaluate therapeutic mechanisms and modes of action for interventions including pharmaceuticals, neurostimulation, digital therapies, and other cognitive/behavioral health interventions.
- Identify and/or test novel pharmacological and non-pharmacological therapeutic targets.
- Improve their understanding of how age, race/ethnicity, and/or comorbidities impact the diagnosis, prognosis, and treatment effectiveness.
- Transdiagnostic investigations and research that bring them closer to precision psychiatry will be given special attention. Illustrative examples include metabolomics biomarkers, gut microbiome-brain interactions, psychedelics, closed-loop neurostimulation, natural language processing (NLP)-based biomarkers, and predictive analytics-based models for evaluating risk or treatment efficacy.
- Applicants must be independent investigators (faculty or equivalent) already employed at the rank of assistant or associate professor (or equivalent) in a non-profit (public or private) academic or non-academic research institution.
- Applicants should be within 10 years of their initial independent appointment to qualify as an ECI.
- Applicants will have a doctoral level degree (e.g., MD, PhD, PsyD, PharmD, etc.) with demonstrated academic excellence and research productivity in scientific fields that can be applied to the study of psychiatric disorders.
- One Mind encourages applications from underrepresented minorities and women. There are no citizenship or geographical restrictions. International applicants are welcome to apply.
- Pre-doctoral students, postdoctoral fellows, and professors are not eligible to apply.
- Applicants can apply for the award only one time per year for a maximum of three times in their career.
- One Mind reserves the sole right to decide if an applicant meets the eligibility requirements.
- To qualify as an early career investigator, candidates should be within 10 years of their initial independent appointment as an assistant professor for academic institutions or equivalent for non-academic positions. Note that postdoctoral fellows are ineligible.
- Candidates should have demonstrated productivity and innovation in a scientific field that can be applied to the study of neuropsychiatric disorders, such as anxiety, addiction, bipolar disorder, depression, posttraumatic stress, schizophrenia, traumatic brain injury, suicidality, and other serious psychiatric illnesses.
- Awardees will be invited to attend One Mind’s Annual Music Festival for Brain Health activities on September 8-9, 2023 in Napa Valley and give a presentation about their award-winning research plans at the Music Festival’s Scientific Symposium.
- The proposal should not overlap with existing funding.
For more information, visit One Mind.